期刊文献+

妊娠期高血压疾病患者胎盘MMP-2及TIMP-2的表达及意义 被引量:1

The Expression and Significance of Matrix Metalloproteinase-2 and Tissue Inhibitors of Metalloproteinase-2 in Placenta in Patients with Hypertensive Disorder Complicating Pregnancy
下载PDF
导出
摘要 目的:探讨妊娠期高血压疾病患者胎盘组织中基质金属蛋白酶-2(Matrix metalloproteinase-2,MMP-2)、特异性组织抑制剂-2(tissue inhibitors of metalloproteinase-2,TIMP-2)的水平变化。方法:运用免疫组化法检测43例妊娠期高血压疾病患者(实验组)(妊娠期高血压13例、子痫前期30例)、15例正常妊娠孕妇(对照组)胎盘组织中MMP-2、TIMP-2的表达。结果:MMP-2、TIMP-2在胎盘中的表达位于绒毛的合体滋养细胞。MMP-2在实验组的表达显著低于对照组(P<0.05)。TIMP-2的表达在实验组和对照组的表达无显著差异(P>0.05)。MMP-2/TIMP-2在实验组显著低于对照组(P<0.05)。结论:MMP-2、MMP-2/TIMP-2比值的异常可能通过影响滋养细胞的浸润功能而影响胎盘血管床的发育,参与妊娠期高血压疾病的发病。 Objective : To evaluate the changes of the levels of MMP - 2 and TIMP - 2 in placenta of patients with hypertensive disorder complicating pregnancy and normal pregnancy. Methods:43 hypertensive pregnant women (the study group), encluding 13 patients with gestational hypertension and 30 patients with preeclampsia, and 15 normal pregnant women (the control group) were enrolled. Results : MMP - 2 and TIMP - 2 were expressed in syncytiotrophocyte. The expression of MMP - 2 in the study group was markedly lower than that in the control group. There was no evidently difference about the expression of TIMP - 2 between the study and control group.The proportion of MMP- 2 and TIMP- 2 in the study group is significantly lower than that in the control group. Conclusion : The abnormal expression of MMP - 2 and MMP - 2/TIMP - 2 in placental tissue in hypertensive disorder complicating pregnancy may influnced the development of the blood vessel of placenta by influnced the corrasion of trophocyte,which may participate in the pathogenesis of hypertensive disorder complicating pregnancy.
出处 《长治医学院学报》 2009年第3期176-179,共4页 Journal of Changzhi Medical College
关键词 妊娠期高血压疾病 基质金属蛋白酶-2 组织抑制物-2 Hypertensive disorder complicating pregnancy Matrix metalloproteinase - 2 Tissue inhibitors of metalloproteinase -2
  • 相关文献

参考文献9

  • 1Bischof P,Campana A.A putative role for oncogenes in trophoblast inva sion.Hum Reprod,2000,15(Suppl6):51-58.
  • 2Kelly BA,Bond BC,Poston L.Gestational profile of matrix metalloprotei nases in rat uterine artery.Mol Hum Reprod,2003,9(6):351-358.
  • 3Hurst PR,Palmay RD.Matrix matalloproteinase and their endogenous inhi bitors d uring the implantation period intenratuterus.Reprod Ferti Dev,1999,11(78):395- 402.
  • 4Isaka K,Usuda S,Ito H,et al.Expression and activity of matrix metall oproteina se-2 and -9 in human trophoblasts.Placenta,2003,24:53-64.
  • 5Ngugen M,Arkell J,Jackson CJ.Human endothelial gelatinases and angiog enesis.Int J Biol,2001,33(10):960-970.
  • 6杨昀,邹丽.妊娠早中期尿中MMP-9蛋白表达与妊高征初筛[J].实用医学杂志,2004,20(4):387-389. 被引量:2
  • 7Widschwendter M,Schrocksnadel H,Mortl MG.Pre-eclampsia:a disorder of placenta l mitochondria?Mol Med Today,1998,4(7):286-291.
  • 8Mervil P,Evain-Brion D,Challoer JC,et al.The molecular basis of embr yo implan tation in implantation in human.Ientralbl Gynakol,2001,123(6):328-329.
  • 9Ilczynski JR,Tchorzewski H,GlowackaE,et al.Cytokine secretion by decidual ly mphocytes in transient hypertension of pregnancy and preeclampsia.Mediators Infl amm,2002,11(2):105-111.

二级参考文献16

  • 1Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia.Lancet, 2001,357(9249) :53 - 56.
  • 2Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol, 2001, 17(1 ) :463 - 516.
  • 3MacDougall JR, Matrisian LM. Contributions of tumour and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev, 1995, 14(4) :531 - 562.
  • 4Niu R, Okamoto T, lwase K, et al. Quantitative analysis of matrix metalloproteinases-2 and 9, and their tissue inhibitors-1 and -2 in human placenta throughout gestation. Life Sci, 2000,66 (12) : 1127 - 1137.
  • 5Narumiya H, Zhang Y, Fermandez-Patron C, et al. Matrix metalloproteinase-2 is elevated in the plasma of women with preeclampsia. Hypertens Pregnancy, 2001, 20(2) : 185 - 194.
  • 6Moses MA, Wiederschain D, Loughlin KR, et al. Increased incidence of matrix metalloproteinases in urine of cancer patients. Cancer Res, 1998,58(7) : 1395 - 1399.
  • 7Das C, Kumar VS, Gupta S, et al. Network of cytokines, integrins and hormones in human trophohlast cells. J Reprod Immunol, 2002, 53(1-2) :257 - 268.
  • 8Huppertz B, Kertschanska S, Demir AY, et al. Immunohistochemistry of matrix metalloproteinases (MMP), their substrates, and their inhibitors (TIMP) during trophoblast invasion in the human placenta. Cell Tissue Res, 1998, 291(1):133- 148.
  • 9Huppertz B, Kertschanska S, Demir AY, et al. Immunohistochemistry of matrix metalloproteinases (MMP), their substrates, and their inhibitors (TIMP) during trophoblast invasion in the human placenta. Cell Tissue Res, 1998, 291(1):133- 148
  • 10MacDougall JR, Matrisian LM. Contributions of tumour and stromal matrix metalloproteinases to tumor progression, invasion and metastasis.Cancer Metastasis Rev, 1995, 14(4) :531 - 562

共引文献1

同被引文献18

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部